SCHEMBL28048048

SCHEMBL28048048

CCOc1cc(Cl)c(C#N)c(Br)c1OCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
LMNA P02545 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP2C9 P11712 1/20 0.43
HTT P42858 4/20 0.42
POLB P06746 1/20 0.42
ALOX15 P16050 1/20 0.42
ALDH1A1 P00352 6/20 0.39
SMN1; SMN2 Q16637 1/20 0.36
TRPV4 Q9HBA0 1/20 0.35
PDE3A Q14432 1/20 0.35
TSHR P16473 1/20 0.35
PKM P14618 1/20 0.35
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
THRB P10828 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14736116 0.81 THRB (0.34) KDM4ELMNACYP1A2CYP3A4CYP2C19
SCHEMBL14742479 0.80 KDM4E (0.32) KDM4ELMNACYP1A2CYP3A4CYP2C19
SCHEMBL14736127 0.80 POLB (0.33) KDM4ELMNACYP1A2CYP3A4CYP2C19
SCHEMBL9929220 0.80 LMNA (0.34) KDM4ELMNACYP1A2CYP3A4CYP2C19
SCHEMBL9954200 0.79 HTR2A (0.36) KDM4ELMNACYP1A2CYP3A4CYP2C19
SCHEMBL9929200 0.79 TSHR (0.39) KDM4ELMNACYP3A4HTTPOLB
SCHEMBL14742217 0.79 CYP1A2 (0.34) KDM4ELMNACYP1A2CYP3A4CYP2C19
SCHEMBL28114068 0.78 HPGD (0.41) KDM4ELMNAHTTPOLBALOX15
SCHEMBL28825372 0.75 KDM4E (0.41) KDM4ELMNACYP1A2CYP3A4CYP2C19
SCHEMBL9952820 0.73 THRB (0.36) LMNAHTTPOLBALOX15ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106986867-B Heterocycle amine as PI3K inhibitor 因塞特控股公司 2019-06-28 CN disclosed
CN-109010343-A The purposes of Pyrazolopyrimidine derivative treatment PI3K δ associated disease 因赛特公司 2018-12-18 CN disclosed
CN-104024253-B Heterocyclic amines as PI3K inhibitors INCYTE HOLDINGS CORP. (US) 2016-11-30 CN disclosed
CN-105120871-A Use of pyrazolopyrimidine derivatives for the treatment of PI 3K-related disorders INCYTE CORP 2015-12-02 CN disclosed